Join to View Full Profile
1115 BroadwayNew York, NY 10020
Phone+1 646-373-2753
Fax+1 212-582-0888
Dr. Vando is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Leonardo Vando is a psychiatrist based in New York, NY, with a subspecialty in addiction. He completed his fellowship in Addiction Psychiatry and his residency in Psychiatry at the Icahn School of Medicine at Mount Sinai (Beth Israel). He graduated from the Ponce Health Sciences University School of Medicine in 2001. His recent publications focus on the efficacy of at-home, telehealth-supported ketamine treatment for depression and anxiety, with his work being cited multiple times. Dr. Vando has also been involved in clinical trials, specifically regarding the treatment of opioid use disorder.
Education & Training
Icahn School of Medicine at Mount Sinai (Beth Israel)Fellowship, Addiction Psychiatry, 2005 - 2006- Icahn School of Medicine at Mount Sinai (Beth Israel)Residency, Psychiatry, 2001 - 2005
Ponce Health Sciences University School of MedicineClass of 2001
Certifications & Licensure
GA State Medical License 2026 - 2028
NY State Medical License 2005 - 2028
MT State Medical License 2022 - 2028
MO State Medical License 2022 - 2027
WV State Medical License 2022 - 2027
TX State Medical License 2022 - 2027
SD State Medical License Active through 2027
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Addiction Psychiatry
- Join now to see all
Clinical Trials
- OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder Start of enrollment: 2021 Jun 30
Roles: Contact
Publications & Presentations
PubMed
- 14 citationsAt-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data.David S Mathai, Thomas D Hull, Leonardo Vando, Matteo Malgaroli
Journal of Affective Disorders. 2024-09-15 - 37 citationsAt-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: Findings from a large, prospective, open-label...Thomas D Hull, Matteo Malgaroli, Adam Gazzaley, Teddy J Akiki, Alok Madan
Journal of Affective Disorders. 2022-10-01
Press Mentions
People Are Injecting Ketamine at HomeAugust 27th, 2024- Americans Take Ketamine at Home for Depression with Little OversightOctober 30th, 2022
- Ketamine Therapy at Home Effective for Treating Anxiety, DepressionJuly 22nd, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
